Institutional investors purchased a net $4.9 million shares of MNKD during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 25.03% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEERFIELD MANAGEMENT COMPANY LP Bought 5.2 Million shares of MannKind Corp
SCOPIA CAPITAL MANAGEMENT LP Bought 982.9 Thousand shares of MannKind Corp
MORGAN STANLEY & CO. LLC Bought 211.5 Thousand shares of MannKind Corp